Sissetulev dokumentAvalik
Infokiri
Terviseamet · 11. juuni 2025
- Viit
- 5-7/25/432-1
- Registreeritud
- 11. juuni 2025
- Dokumendi liik
- Sissetulev dokument
- Adressaat
- Roche Diagnostic Solutions
- Saabumis/saatmisviis
- e-post
- Funktsioon
- 5 Teabe- ja arhiivihaldus
- Sari
- 5-7 Teabenõuded, selgitustaotlused, märgukirjad (sh avaldused, kaebused, taotlused jm pöördumised)
- Toimik
- 5-7/2025
- Vastutaja
- Liivi Zovo
Sisu (failidest)
Saatja: "Sobczak, Rachael" <[email protected]>
Saaja: [email protected]
Teema: SAE Notification - Performance Study 2023-504753-12-00
Kuupäev: 2025-06-10 22:02
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Dear Sir/Madam,
Please find attached an IVD SAE Report form (IVDR Performance Study Summary
Safety Reporting Form MDCG 2024-4 Appendix) for the IVD Performance
Evaluation with PSP code RD006691.
The SAE is related to a study procedure (sample collection) occurring
outside Estonia, and does not directly involve patients in Estonia. Testing
with the IVD device occurred in Edinburgh, Scotland. The event is reported
as the study procedures and testing are conducted under the same IVD
protocol that will be used for Estonian patients. The device manufacturer
causality assessment has found that the SAE was not related to the device.
Please advise if any additional information is required.
Kind regards,
Rachael Sobczak
Global Studies Leader
IQVIA Agent representing Roche Diagnostic Solutions
Mobile: 317-965-7205
Email: <mailto:[email protected]>
[email protected]
Upcoming OOO: N/A